Shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) have been given an average rating of “Hold” by the twenty-five analysts that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, fifteen have given a hold recommendation and eight have given a buy recommendation to the company. The average 12 month […]
